Kaymaz Burçin Tezcanlı - Medical Biology Department, Ege University Medical School

基本信息

浏览量：10

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 61 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Investigating the Effects of a Synthetic Cannabinoid on the Pathogenesis of Leukemia and Leukemic Stem Cells: A New Therapeutic Approach

Hilal Salcin,Bakiye Goker Bagca,Ilayda Alcitepe, Cigir Biray Avci,Rukiye Aslan,Serap Annette Akgur,Burcin Tezcanli Kaymaz

CANNABIS AND CANNABINOID RESEARCHno. 1 (2024): 212-222

引用1浏览0WOS引用

Nilotinib Exerts a Therapeutic Approach Via JAK/STAT Pathway and Cytokine Network in Chronic Myeloid Leukemia Cells

Burçin TEZCANLI KAYMAZ, Tunzala YAVUZ, Besne ÇELİK,Leila SABOUR TAKANLOU,İlayda ALÇITEPE,Maryam SABOUR TAKANLOU,Çığır AVCI,Nur SELVİ GÜNEL,Nur SOYER,Fahri ŞAHİN,Güray SAYDAM

Ege Tıp Dergisino. 1 (2024): 124-135

引用0浏览0引用

Ponatinib and STAT5 Inhibitor Pimozide Combined Synergistic Treatment Applications Potentially Overcome Drug Resistance Via Regulating the Cytokine Expressional Network in Chronic Myeloid Leukemia Cells

Burcin Tezcanli Kaymaz,Nurcan Gumus, Besne Celik,Ilayda Alcitepe, Cigir Biray Avci,Cagdas Aktan

JOURNAL OF INTERFERON AND CYTOKINE RESEARCHno. 4 (2024): 178-189

引用0浏览0WOS引用

The Roles of the Golgi in Various Diseases

Hilal Salcin,Burcin Tezcanli Kaymaz

CLINICAL AND EXPERIMENTAL HEALTH SCIENCESno. 1 (2024): 264-272

引用0浏览0引用

STAT5 inhibitor Pimozide as a probable therapeutic option in overcoming Ponatinib resistance in K562 leukemic cells

Nurcan Gumus,Cumhur Gunduz,Burcin Tezcanli Kaymaz

J Biomol Struct Dyn（2023）

引用1浏览0WOS引用

Targeting UPR Signaling Pathway by Dasatinib As a Promising Therapeutic Approach in Chronic Myeloid Leukemia

Ozel Buket,Kipcak Sezgi,Biray Avci Cigir,Sabour Takanlou Maryam,Sabour Takanlou Leila,Tezcanli Kaymaz Burcin,Karatekin Ilknur,Gunduz Cumhur,Selvi Gunel Nur

Medical Oncology（2022）

引用0浏览0WOS引用

Investigating the Potential Therapeutic Role of Targeting STAT3 for Overcoming Drug Resistance by Regulating Energy Metabolism in Chronic Myeloid Leukemia Cells

Burcin Tezcanli Kaymaz,Nur Selvi Gunel,Fatma Sogutlu,Neslihan Pinar Ozates Ay,Yusuf Baran,Cumhur Gunduz, Cigir Biray Avci

DOAJ (DOAJ Directory of Open Access Journals)（2022）

引用0浏览0WOS引用

Miyelodisplastik Sendrom Hastalığında P53 Polimorfizmlerinin Önemi

Bahar VATANSEVER,Duygu AYGÜNEŞ JAFARİ,Hale GÜLER KARA, Ege SEVİNÇ,Burçin KAYMAZ,Gülay ALP,Fahri ŞAHİN,Güray SAYDAM,Buket KOSOVA

Ege Tıp Dergisino. 2 (2022): 259-268

引用0浏览0引用

HDAC Inhibitor Vorinostat and BET Inhibitor Plx51107 Epigenetic Agents’ Combined Treatments Exert a Therapeutic Approach Upon Acute Myeloid Leukemia Cell Model

Alcitepe İlayda,Salcin Hilal,Karatekin İlknur,Kaymaz Burcin Tezcanli

openalex（2022）

引用5浏览0引用

Functional Roles of Mir-625-5p and Mir-874-3p in the Progression of Castration Resistant Prostate Cancer

Cagdas Aktan,Cag Cal,Burcin Kaymaz,Nur Selvi Gunel,Sezgi Kipcak,Buket Ozel,Cumhur Gunduz,Ali Sahin Kucukaslan,Duygu Ayguenes Jafari,Buket Kosova

Life Sciences (2022): 120603-120603

引用1浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn